So here's a company that makes aluminum parts for airplanes, and it just signed a nice, long-term deal to keep making those parts for one of the biggest airplane makers in the world. That's the kind of news that tends to make investors happy, and sure enough, shares of Constellium SE (CSTM) moved higher in Tuesday's premarket trading.
The deal is with Airbus SE (EADSY), and it's a multi-year agreement for Constellium to supply aluminum alloy extrusions. This isn't just some random contract—it's the kind of arrangement that locks in business for years and tells you the customer really trusts your quality and reliability.
What's Actually in the Deal?
This agreement basically cements Constellium's role as a go-to supplier for Airbus. They'll be delivering a whole range of advanced aluminum products, including bars, various sizes of extrusions, and their special aluminum-lithium solution called Airware. That last one is designed for high-performance aircraft structures, which is exactly where you want to be if you're supplying the aerospace industry.
The production will happen at Constellium's facilities in France, which makes sense given Airbus's European roots. The company's aerospace and transportation president, Philippe Hoffmann, put it pretty clearly: "This agreement reflects Airbus' trust in our advanced aluminum products and solutions, and in our quality performance, industrial reliability and consistent supply continuity to support long-term aerospace programs."
For context, Constellium serves aircraft, defense, and space markets, and it pulled in $8.4 billion in revenue last year. So this Airbus deal is happening within a pretty substantial business.
The Stock Is Looking Strong (Maybe Too Strong?)
Here's where it gets interesting for investors. Constellium is trading right near its 52-week high, which is always a good sign if you own the stock. The technical indicators tell a bullish story: the stock is trading 14.3% above its 20-day simple moving average and 36.1% above its 100-day average. That suggests both short-term and intermediate-term momentum are pointing up.
The MACD indicator is above its signal line, which is another bullish signal suggesting the upward trend might continue. But here's the thing that might give you pause—the relative strength index is sitting at 66.44. For those not familiar with RSI, anything above 70 is typically considered overbought territory. So at 66.44, we're getting close to that zone where the stock might be due for a pullback if buying pressure starts to ease up.
If you're watching the technical levels, traders are eyeing $31.50 as a key resistance point (where selling might pick up) and $30.00 as potential support if the stock does retrace a bit.
Earnings Are Just Around the Corner
All of this is happening right before the company reports earnings on April 29. The estimates look pretty encouraging:
- EPS estimate: 55 cents (that's up from 26 cents last year)
- Revenue estimate: $2.22 billion (up from $1.98 billion)
- Valuation: P/E of 15.8x, which suggests a fair valuation
Analysts seem to like what they see. The consensus rating is a Buy with an average price target of $30.75. Some recent moves worth noting: JP Morgan raised its target to $30.00 on April 16, Wells Fargo bumped theirs up to $35.00 the same day, and JP Morgan had already raised it to $29.00 back in February.
How Does the Company Stack Up?
Looking at various ranking metrics, Constellium shows some impressive numbers:
- Value Rank: 76.32 — solid valuation relative to peers
- Growth Rank: 98.24 — exceptional growth profile
- Quality Rank: 97.46 — high-quality financial performance
- Momentum Rank: 97.28 — strong upward price momentum
What this tells you is that the company isn't just riding a temporary wave—it has strong fundamentals backing up that stock price movement. The growth-heavy profile with strong momentum suggests the stock is well-positioned for continued performance.
As of Tuesday's close, Constellium shares were down just 0.16% at $30.23, trading near that 52-week high of $31.20. So the stock gave up its premarket gains during the regular session, but it's still sitting in a pretty strong position heading into earnings.